Into its 9th edition, Biologics World Taiwan has firmly established itself as Taiwan's THE biopharmaceutical gathering for new partnerships, ideas and knowledge. It has doubled its attendee numbers year after year, with 100% of participants judging the conference to be an excellent and beneficial experience. We are proud to continue the meeting platform where Taiwan's growing biopharma industry is at the forefront, receiving more and more global attention on its fast advancement in new biologics drug R&D and biomanufacturing.
While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector and capture a share of the global market. The 2009 national plan for biotech development helped kick-start the sector, which has since doubled in revenue size to reach NT$ 118.6bn (US$3.8bn) in 2019. The main focus is on the development of new drugs and biologics.
Strong government commitment has helped drive the expansion of the biotechnology sector. Two biotechnology clusters have already been built in Taiwan and the official opening of the National Biotechnology Research Park (NBRP) in Taipei City's Nangang District in 2018, marked an important milestone for the biomedical industry, as it will integrate Taiwan's R&D and start-up incubation capabilities, focusing all the pre-clinical trial activity in a single location.
Biologics World Taiwan provides the FIRST and ONLY platform for senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharmas, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry.
Fast Track Biologic Product Commercialization and Market Access
Taiwan’s Developments & Plan for Regenerative Medicine
Lesson Learned on Stem Cells Therapy
Challenges & Opportunities in the Clinical Development & Approval of Novel Therapeutic Antibodies
Clinical Development & Trials for ATMP’s
Discussions on Biologics R&D, Bioprocessing, Stem Cells & Regenerative Medicine
CRO Capability Showcase
Clinical Applications of iPSC’s: Advancements & Case-Studies from Taiwan
Development of Mesenchymal Stem Cell-Related Products for Novel Allogenic Use
Present your expertise to the key biologics stakeholders from Taiwan through a variety of available speaking packages.
Join the exhibition, and build an impressive presence among your potential clients.
Emphasize on your messages by promoting your brand alongside exhibition and thought leadership.
Engage with and build lasting connections that matter the most to your business.
Gain exclusive access to contacts of high-profile attendees through intimate networking opportunities.